Poirier, D.; Roy, J.; Maltais, R.; Weidmann, C.; Audet-Walsh, É.
An Aminosteroid Derivative Shows Higher In Vitro and In Vivo Potencies than Gold Standard Drugs in Androgen-Dependent Prostate Cancer Models. Cancers 2023, 15, 3033.
https://doi.org/10.3390/cancers15113033
AMA Style
Poirier D, Roy J, Maltais R, Weidmann C, Audet-Walsh É.
An Aminosteroid Derivative Shows Higher In Vitro and In Vivo Potencies than Gold Standard Drugs in Androgen-Dependent Prostate Cancer Models. Cancers. 2023; 15(11):3033.
https://doi.org/10.3390/cancers15113033
Chicago/Turabian Style
Poirier, Donald, Jenny Roy, René Maltais, Cindy Weidmann, and Étienne Audet-Walsh.
2023. "An Aminosteroid Derivative Shows Higher In Vitro and In Vivo Potencies than Gold Standard Drugs in Androgen-Dependent Prostate Cancer Models" Cancers 15, no. 11: 3033.
https://doi.org/10.3390/cancers15113033
APA Style
Poirier, D., Roy, J., Maltais, R., Weidmann, C., & Audet-Walsh, É.
(2023). An Aminosteroid Derivative Shows Higher In Vitro and In Vivo Potencies than Gold Standard Drugs in Androgen-Dependent Prostate Cancer Models. Cancers, 15(11), 3033.
https://doi.org/10.3390/cancers15113033